Corporate Presentation - CTX Lifescience Pvt Ltd
Download
Report
Transcript Corporate Presentation - CTX Lifescience Pvt Ltd
Chemistry support for
building partnerships
CTX LIFESCIENCES PVT LTD
An integrated Partner throughout API Cycle
US FDA/EU GMP Certified/PMDA Accreditation
and compliant
Who we are
Colourtex, a 40-year old largest dyes and intermediates
company in India with over 2000 employees and annual
revenues of USD 250 millions, diversified into
Pharmaceuticals in 2004
Privately held Company headquartered in Surat, 260 kms
north of Mumbai. Surat - a major hub for Chemicals and
Diamonds
Commercial production started in the state-of-the-art greenfield facility during second quarter of 2006
Presence in anti-infectives, CVS, CNS, anti-diabetes and
other segments
Our Vision
To be the preferred strategic partner for the
pharmaceutical industry and share responsibilities &
goals for the enhancement of human health.
Our Mission
To develop and manufacture Active
Pharmaceutical Ingredients and Intermediates
for global supply complying to quality and
regulatory requirements of our customers.
Our Mfg Strengths and Plans
US FDA inspected and accepted facility, EUGMP
Certified and Japan Accredited with over 200,000 sq.ft
area spread on 38 acres of land. One facility for all
markets. Large intermediate plant.
Cost effective operating structure with vertical integration
in some products
Skilled workforce and competent technical & management
team with global and global pharma experience
Total number of reactors : 83 Nos.
Total reactors volume : 236 meter cube
Total number of people : 296
Our Mfg Strengths and Plans
Access to own large infrastructure, viz. water reservoirs,
power generation, effluent treatment plant, landfill site and
incinerators. Also, large intermediate plant
Can handle complex chemical reactions viz., cynation,
nitration, chlorosulfonation, hydrogenation and ethoxylation
Investment over USD 27 millions
US DMF filed for 18 products and 5 approved. CEP filed for
9 products and 8 approved.
Validations completed for Quetiapine and Candesartan
Product Range
Acetazolamide
Amiodarone
Alendronate Sodium
Carbamazepine
Carvedilol
Chlorothiazide
Colesevelam
Candesartan
Hydrochlorothiazide
Irbesartan
Lamotrigine
Metoprolol Tartrate/Succinate
Olmesartan
Oxcarbazepine
Oxymetazoline/Xylometazoline
Pregabalin
Quetiapine
Sevelamer HCl/Carbonate
Terazosin
Terbinafine
Why partner with CTX Lifesciences
•
Chemistry competence over forty years
•
Excellent infrastructure viz. water, power, disposal of gaseous, liquid and solid organic
wastes and financial strength
•
cGMP compliant state of the art facility with focus on API and Intermediates. Facility
audited by Astra Zeneca, Glaxo, Novartis, EMerck, Aventis,, Teva, Mylan, Sandoz,
Actavis, Siegfried, Pliva and visit by Pfizer and found to comply their requirements.
•
US FDA inspected and accepted facility; PMDA accreditation and EUGMP Certified.
•
Plan to file at least 5 DMFs in 2013
•
Experienced technical and commercial team with global and global pharma
experience.
•
Vertical integration on Hydrochlorothiazide, Xylometazoline, Oxymetazoline, Irbesartan
Sevelamer, Colesevalam, and Lamotrigine and working on Metoprolol Tartrate,
Succinate and Oxcarbazepine
•
Environment, Safety and Health Practices
Manufacturing and R&D
Thank You